Breaking News
Get 60% Off 0
Cyber Monday Deal: Up to 60% off InvestingPro
CLAIM SALE
Close

Elevance Health Inc (ELV)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Elevance Health's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
408.07 -2.32    -0.57%
02:29:59 - Closed. Currency in USD
After Hours
409.15
+1.08
+0.26%
6:27:37 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 1,692,129
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 406.78 - 412.34
Elevance Health 408.07 -2.32 -0.57%

NYSE:ELV Financials

 
Gain a comprehensive overview of Elevance Health financials. Assess key figures from the balance sheet and income statement. Explore essential metrics such as total assets, total liabilities, equity, revenue, and net income to understand the company’s overall financial performance.

Elevance Health, Inc. reported earnings results for the third quarter and nine months ended September 30, 2024. For the third quarter, the company reported revenue was USD 45,106 million compared to USD 42,849 million a year ago. Net income was USD 1,016 million compared to USD 1,289 million a year ago. Diluted earnings per share from continuing operations was USD 4.36 compared to USD 5.45 a year ago. For the nine months, revenue was USD 131,569 million compared to USD 128,693 million a year ago. Net income was USD 5,562 million compared to USD 5,131 million a year ago. Diluted earnings per share from continuing operations was USD 23.81 compared to USD 21.56 a year ago.

AnnualQuarterly  
Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

ELV Income Statement

Gross margin TTM 27.94%
Operating margin TTM 6.1%
Net Profit margin TTM 3.69%
Return on Investment TTM 12.08%
 Total Revenue  Net Income
Period Ending: Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023
Total Revenue 45145 43646 42577 42647
Gross Profit 12196 13074 12031 11313
Operating Income 1980 3026 3204 2404
Net Income 1016 2300 2246 856

ELV Balance Sheet

Quick Ratio MRQ 1.07
Current Ratio MRQ 1.5
LT Debt to Equity MRQ 56.4%
Total Debt to Equity MRQ 62.02%
 Total Assets  Total Liabilities
Period Ending: Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023
Total Assets 116533 112988 111894 108928
Total Liabilities 72654 70691 71184 69523
Total Equity 43879 42297 40710 39405

ELV Cash Flow Statement

Cash Flow/Share TTM 9.19
Revenue/Share TTM 750.43
Operating Cash Flow  6.37%
 Cash  Net Change in Cash
Period Ending: Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities 2677 447 1978 -2971
Cash From Investing Activities -401 -818 -2310 -1029
Cash From Financing Activities -915 668 32 -394
Net Change in Cash 1369 271 -300 -4393
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ELV Comments

Write your thoughts about Elevance Health Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email